FDA Calendar

Wednesday, August 3, 2011

$DSCO on tractk to file CR in Q3 with FDA on Surfaxin.

http://www.marketwatch.com/story/discovery-labs-reports-second-quarter-financial-results-and-provides-an-update-on-lead-pipeline-programs-2011-08-03?reflink=MW_news_stmp
Posted by Biotechtrader34 at 9:21 AM
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)